Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Acq. announced
|
|
ASSEMBLY BIOSCIENCES, INC. (ASMB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2014 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger and Reorganization, by and among Ventrus Biosciences, Inc. and Assembly Acquisition, Inc., Assembly Pharmaceuticals, Inc",
"VENTRUS BIOSCIENCES TO MERGE WITH ASSEMBLY PHARMACEUTICALS ~ New Company, Assembly Biosciences, to Focus on First-in Class Technology for Treatment and Potential Cure of Hepatitis B Virus Infection, Affecting 350 Million Worldwide ~ Projected Multi-Billion Market Opportunity; No Curative Therapy Exists ~ Combined Teams Bring Experienced Leadership Capable of Driving Value ~ Anticipated Closing July 10, 2014, Pending Shareholder Approval MAY 19, 2014 –Ventrus Biosciences, Inc. has entered into a merger agreement with Assembly Pharmaceuticals, a privately held biopharmaceutical company, in an all-stock transaction. Upon the completion of the merger the combined company will be renamed Assembly Biosciences, Inc. and trade on the Nasdaq Capital Market under the ticker “ASMB.” Once the merger i..." |
|
|
|